Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bulent Arman Aksoy

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
BMC Bioinformatics|September 4, 2019
Cytokit: a single-cell analysis toolkit for high dimensional fluorescent microscopy imagingEric Czech, Bulent Arman Aksoy, Pinar Aksoy, et al.
Current Protocols in Bioinformatics|March 19, 2013
Using MEMo to discover mutual exclusivity modules in cancerGiovanni Ciriello, Ethan Cerami, Bulent Arman Aksoy, et al.
Frontiers in Immunology|February 7, 2018
Computational Pipeline for the PGV-001 Neoantigen Vaccine TrialAlex Rubinsteyn, Julia Kodysh, Isaac Hodes, et al.
Cell Systems|September 3, 2018
Coral: Clear and Customizable Visualization of Human Kinome DataKathleen S Metz, Erika M Deoudes, Matthew E Berginski, et al.
Cancer Immunology Research|December 14, 2016
Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 BlockadeTavi Nathanson, Arun Ahuja, Alexander Rubinsteyn, et al.
Frontiers in Immunology|October 17, 2017
PI3Kδ Inhibition Enhances the Antitumor Fitness of Adoptively Transferred CD8<sup>+</sup> T CellsJacob S Bowers, Kinga Majchrzak, Michelle H Nelson, et al.
Cancer Immunology Research|June 27, 2019
Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor ControlEmilio Sanseviero, Erin M O'Brien, Jenna R Karras, et al.
The Journal of Clinical Investigation|January 30, 2019
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapyTori N Yamamoto, Ping-Hsien Lee, Suman K Vodnala, et al.
Plos Medicine|May 30, 2017
Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysisAlexandra Snyder, Tavi Nathanson, Samuel A Funt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 26, 2025
IL-2-independent expansion, persistence, and antitumor activity in TIL expressing regulatable membrane-bound IL-15Rachel A Burga, Bulent Arman Aksoy, Zheng Ao, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
BMC Bioinformatics|September 4, 2019
Cytokit: a single-cell analysis toolkit for high dimensional fluorescent microscopy imagingEric Czech, Bulent Arman Aksoy, Pinar Aksoy, et al.
Current Protocols in Bioinformatics|March 19, 2013
Using MEMo to discover mutual exclusivity modules in cancerGiovanni Ciriello, Ethan Cerami, Bulent Arman Aksoy, et al.
Frontiers in Immunology|February 7, 2018
Computational Pipeline for the PGV-001 Neoantigen Vaccine TrialAlex Rubinsteyn, Julia Kodysh, Isaac Hodes, et al.
Cell Systems|September 3, 2018
Coral: Clear and Customizable Visualization of Human Kinome DataKathleen S Metz, Erika M Deoudes, Matthew E Berginski, et al.
Cancer Immunology Research|December 14, 2016
Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 BlockadeTavi Nathanson, Arun Ahuja, Alexander Rubinsteyn, et al.
Frontiers in Immunology|October 17, 2017
PI3Kδ Inhibition Enhances the Antitumor Fitness of Adoptively Transferred CD8<sup>+</sup> T CellsJacob S Bowers, Kinga Majchrzak, Michelle H Nelson, et al.
Cancer Immunology Research|June 27, 2019
Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor ControlEmilio Sanseviero, Erin M O'Brien, Jenna R Karras, et al.
The Journal of Clinical Investigation|January 30, 2019
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapyTori N Yamamoto, Ping-Hsien Lee, Suman K Vodnala, et al.
Plos Medicine|May 30, 2017
Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysisAlexandra Snyder, Tavi Nathanson, Samuel A Funt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 26, 2025
IL-2-independent expansion, persistence, and antitumor activity in TIL expressing regulatable membrane-bound IL-15Rachel A Burga, Bulent Arman Aksoy, Zheng Ao, et al.
Pageof 2